|
Volumn 51, Issue 5, 2010, Pages 713-719
|
Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2',3' DIDEOXYNUCLEOSIDE DERIVATIVE;
3' FLUOROTHYMIDINE;
BIOLOGICAL MARKER;
DIAGNOSTIC AGENT;
IDOXURIDINE;
KI 67 ANTIGEN;
RADIOPHARMACEUTICAL AGENT;
THYMIDINE KINASE;
THYMIDINE KINASE 1;
ARTICLE;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
FEMALE;
HUMAN;
IMAGE PROCESSING;
IMMUNOHISTOCHEMISTRY;
MALE;
METABOLISM;
MIDDLE AGED;
MOUTH TUMOR;
PATHOLOGY;
PHOSPHORYLATION;
POSITRON EMISSION TOMOGRAPHY;
REPRODUCIBILITY;
SCINTISCANNING;
SQUAMOUS CELL CARCINOMA;
BIOLOGICAL MARKERS;
CARCINOMA, SQUAMOUS CELL;
DIDEOXYNUCLEOSIDES;
FEMALE;
HUMANS;
IDOXURIDINE;
IMAGE PROCESSING, COMPUTER-ASSISTED;
IMMUNOHISTOCHEMISTRY;
KI-67 ANTIGEN;
MALE;
MIDDLE AGED;
MOUTH NEOPLASMS;
PHOSPHORYLATION;
POSITRON-EMISSION TOMOGRAPHY;
RADIOPHARMACEUTICALS;
REPRODUCIBILITY OF RESULTS;
THYMIDINE KINASE;
TOMOGRAPHY, EMISSION-COMPUTED;
MLCS;
MLOWN;
|
EID: 77952302439
PISSN: None
EISSN: 15355667
Source Type: Journal
DOI: 10.2967/jnumed.109.071910 Document Type: Article |
Times cited : (22)
|
References (0)
|